Die Differentialdiagnose der generalisierten Tendomyopathie

  • B. Müller
Conference paper

Summary

Chronic widespread and diffuse aching at many sites, and multiple tender points at characteristic locations lead to a wide differential diagnosis: psychiatric disturbances, mild and early forms of inflammatory and systemic rheumatic diseases, osteoarthritis and osteoporosis with tendomyotic character, generalized crystal-associated synovitis, endocrinological disorders, infections diseases, and drug-related side effects to enumerate the most frequent possibilities. We particularly examine chronic fatigue syndrome as a phenomenon similar to fibromyalgia, and we discuss the questionable role of Ebstein-Barr virus.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Ahles TA, Yunus MP, Riley SD, Bradley JM, Masi AT (1984) Psychological factors associated with primary fibromyalgia syndrome. Arthritis Rheum 27: 1101–1106PubMedCrossRefGoogle Scholar
  2. 2.
    Alonso-Ruiz A, Hoz-Martinez A, Zea-Mendoza A (1985) Fibromyalgia syndrome as a late complication of toxic-oil syndrome. J Rheumatol 12: 1207–1208PubMedGoogle Scholar
  3. 3.
    Bengtsson A, Hendriksson KG, Larsson J (1986) Muscle Biopsy in primary Fibromyalgia. Scand J Rheumatol 15: 1–6PubMedCrossRefGoogle Scholar
  4. 4.
    Benoist M, Kahn MF (1987) Le syndrome polyalgique idiopathique diffus. In: Sèze S de, Ryckewaert A de, Kahn MF, Guerin C (1987) L’actualité rhumatologique 1987. Expansion éd, ParisGoogle Scholar
  5. 5.
    Buchwald D, Goldenberg DL, Sullivan JL et al (1987) The “chronic active Epstein-Barr virus infection” syndrome and primary fibromyalgia. Arthritis Rheum 30: 1132–1136PubMedCrossRefGoogle Scholar
  6. 6.
    Caro XJ et al (1986) A controlled and blindes study of immunoreactant deposition at the dermal- epidermal junction of patients with primary fibrositis syndrome. J Rheumatol 13: 1086–1092PubMedGoogle Scholar
  7. 7.
    Dinerman H, Goldenberg DL, Felson DT (1986) A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud’s phenomenon, Sicca symptoms, ANA, low complement and Ig Deposition at the dermal-epidermal junction. J Rheumatol 13: 368–373Google Scholar
  8. 8.
    Goldenberg DL (1988) Fibromyalgia and other chronic fatigue syndrome: Is there evidence for chronic viral disease? Sem Arthritis Rheum 18: 111–120CrossRefGoogle Scholar
  9. 9.
    Goldenberg DL (1989) Psychiatric and psychologic aspects of fibromyalgia syndrome. Rheum Dis Clin North Am 15: 105–114PubMedGoogle Scholar
  10. 10.
    Hench PK (1986) Secondary fibrositis. Am J Med 81 (Suppl 3a): 60–62PubMedCrossRefGoogle Scholar
  11. 11.
    Holmes GP, Kaplan JE, Nelson M et al. (1988) Chronic fatigue syndrome: a working case definition. Ann Int Med 108: 387–389PubMedGoogle Scholar
  12. 12.
    Horwitz CA, Henle W, Henle G et al. (1985) Long-term serological follow-up of patients for Epstein- Barr virus after recovery from infectious mononucleosis. J Infect Dis 151: 1151–1153CrossRefGoogle Scholar
  13. 13.
    Jones JF, Ray CG, Minnich LL et al. (1985) Evidence for active Epstein-Barr virus infection in patients with persistent unexplained illness: elevated anti-early antigen antibodies. Ann Int Med 102: 1–7PubMedGoogle Scholar
  14. 14.
    Kirmayer LJ et al. (1988) Somatization and depression in fibromyalgia syndrome. Am J Psychiatry 145: 950–954PubMedGoogle Scholar
  15. 15.
    Komaroff AL, Geiger AM, Wormsely S (1988) IgG subclass deficiencies in chronic fatigue syndrome. Lancet 1: 1288–1289PubMedCrossRefGoogle Scholar
  16. 16.
    Lamy ME, Favart AM, Cornu C et al. (1982) Study of Epstein-Barr virus antibodies. Acta Clin Belg 37: 281–298PubMedGoogle Scholar
  17. 17.
    Müller W, Schilling F (1982) Differentialdiagnose rheumatischer Erkrankungen, 2. Aufl. Aesopus- Verlag, BaselGoogle Scholar
  18. 18.
    Müller W, Lautenschläger J (1990) Die generalisierte Tendomyopathie (GTM). Teil I: Klinik, Verlauf und Differentialdiagnose. Teil II: Pathogenese und Therapie. Z Rheumatol 49: 11–29Google Scholar
  19. 19.
    Payne TC et al. (1982) Fibrositis and psychologic disturbances. Arthritis Rheum 25: 213–217PubMedCrossRefGoogle Scholar
  20. 20.
    Red D, Spickeit G, Harvey J et al. (1988) IgGl subclass deficiency in patients with chronic fatigue syndrome. Lancet 1: 241–242CrossRefGoogle Scholar
  21. 21.
    Rozenberg S, Kahn MF (1989) Le syndrome de fatigue chronique post-virale ou Yuppie’s syndrome. Cone Med 6: 111–123Google Scholar
  22. 22.
    Straus SE, Tosato G, Armstrong G et al. (1985) Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Int Med 102: 7–16PubMedGoogle Scholar
  23. 23.
    Swartz MN (1988) The chronic fatigue syndrome — one entity or many? N Engl J Med 319: 1726–1728PubMedCrossRefGoogle Scholar
  24. 24.
    Tobi M, Morag A, Ravid Z et al. (1982) Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet 1: 61–63PubMedCrossRefGoogle Scholar
  25. 25.
    Wakefield D, Lloyd A (1987) Pathophysiology of myalgic encephalitis. Lancet 11: 918–919CrossRefGoogle Scholar
  26. 26.
    Wolfe F (1989) Fibromyalgia: the clinical syndrome. Rheum Dis Clin North Am 15: 1–18PubMedGoogle Scholar
  27. 27.
    Wolfe F, Cathey M (1983) Prevalence of primary and secondary fibrositis. J Rheumatol 10: 965–968PubMedGoogle Scholar
  28. 28.
    Yunus MB, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL (1981) Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 11: 151–171PubMedCrossRefGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt 1991

Authors and Affiliations

  • B. Müller
    • 1
  1. 1.Rheumatologische UniversitätsklinikBaselSwitzerland

Personalised recommendations